SpaceX Finally Made It's S-1 Public. 3 Things Smart Investors Need to Know About the IPO

SpaceX is reportedly preparing for what could be the largest IPO in history, with a potential valuation of $1.75 trillion to $2 trillion. The S-1 shows 2025 sales of $18.67 billion but a net loss of $4.9 billion, and Q1 2026 loss widened to $4.27 billion on $4.69 billion of revenue. While Starlink drove 69% of last quarter sales and the company highlights a $28.5 trillion TAM, including $22.7 trillion from AI enterprise applications, the article emphasizes that SpaceX still has substantial execution risk before public-market investors can justify the valuation.

Analysis

The bigger market implication is not the IPO itself, but the pricing power it creates for the whole late-stage private AI/space complex. A $1.75T-$2T debut would reset marks across crossover funds, forcing passive and index-linked buyers to fund a valuation anchored more in narrative durability than near-term cash generation; that usually tightens private-market financing for adjacent names and raises the hurdle for any unprofitable growth story that needs repeated capital access.

The second-order winner is the ecosystem around launch cadence, satellite networking, AI inference infrastructure, and high-end semicap supply, but the near-term listed beneficiaries are likely more indirect than the headline suggests. If investors start underwriting AI TAM at trillion-dollar scale inside a capital-intensive platform company, they may also reward the picks-and-shovels layer while becoming less tolerant of balance-sheet burn elsewhere; that argues for relative-value exposure rather than outright beta.

The core risk is timing: the story can carry the stock on IPO scarcity for months, but the multiple is vulnerable once public-market investors shift from TAM to unit economics and dilution. The first 1-2 earnings prints post-debut will matter more than the listing day; if margins stay deeply negative while growth decelerates, the market will re-rate the name toward other mega-cap “moonshot” debuts that faded after lockup expiration and secondary supply.

Contrarian take: consensus may be underestimating how much this IPO could drain attention and capital from other AI leaders in the short run. That creates a tradable rotation risk into established earnings compounders like NVDA and away from newly listed, story-heavy assets; the likely winner is not the company with the largest TAM slide, but the one already converting AI demand into cash flow today.

Key Decisions for Investors

• Short-dated call spread hedge on IPO-date frenzy: buy exposure to listed AI winners via NVDA calls and fund by selling farther OTM calls into any sympathy bid in story stocks; target 4-8 weeks, looking for rotation once IPO euphoria fades.
• Pair trade: long NVDA / short a basket of high-burn, pre-profit AI exposure proxies for 1-3 months; thesis is that capital rotates toward proven monetization while valuation discipline tightens after the IPO.
• Avoid initiating long exposure into the IPO print unless there is a material first-day discount to the range; if pricing lands at the top end, wait for the first post-lockup volatility window before buying any secondary weakness.
• Watch TSLA only as a sentiment read-through, not a fundamental beneficiary; if the market extrapolates Musk optionality across names, use any strength to fade with tight stops because governance premium can compress quickly when the market demands earnings instead of vision.
• Set a catalyst monitor for the first two quarterly reports after listing; if revenue growth slows by >20% sequentially or losses widen, expect a 15-25% multiple reset over 3-6 months and position for downside via puts or put spreads.